TOUJEO is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Glargine.
| Product ID | 50090-2193_5e6a003a-854a-4097-8994-d35de2f2ec2a |
| NDC | 50090-2193 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TOUJEO |
| Generic Name | Insulin Glargine |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2015-02-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA206538 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | INSULIN GLARGINE |
| Active Ingredient Strength | 300 U/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2015-10-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA206538 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-10-26 |
| Marketing End Date | 2019-01-31 |
| Ingredient | Strength |
|---|---|
| INSULIN GLARGINE | 300 U/mL |
| SPL SET ID: | 257ca17b-6ff7-4f2e-9037-4c185bac5768 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0024-5869 | TOUJEO | insulin glargine |
| 50090-2193 | TOUJEO | TOUJEO |
| 0002-7715 | BASAGLAR | Insulin glargine |
| 0002-8214 | BASAGLAR | Insulin glargine |
| 0088-2220 | Lantus | insulin glargine |
| 0088-2219 | Lantus Solostar | insulin glargine |
| 0024-5871 | TOUJEO Max | insulin glargine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TOUJEO 86327965 4939032 Live/Registered |
Sanofi 2014-07-03 |
![]() TOUJEO 85835283 4469082 Live/Registered |
Sanofi 2013-01-29 |